Best of Hematology and Breast Cancer™ 2026, Boise
Accreditation: 6.75 AMA PRA Category 1 Credit™ | 6.75 ABIM MOC II | 6.75 ACPE Pharmacy | 6.75 Nursing Contact Hours
Venue: The Grove Hotel, 245 South Capitol Boulevard, Boise, ID, United States
Official conference page for Best of Hematology and Breast Cancer™ 2026, Boise. https://binaytara.org/projects/conferences/best-of-hematology-and-breast-cancer-2026-boise
About Best of Hematology and Breast Cancer™ 2026, Boise


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Our Agenda
Saturday, February 28th, 2026
All timings are in Mountain Time (MDT, GMT-06:00) time.
Session Chair: Andrew Scott Pierson, MD
08:20 AM - 08:40 AM
TTP/HUS – Nicole Birrer, MD
08:40 AM - 09:00 AM
Modern Topics in Hemophilia – Ming Y Lim, MBBCh
09:00 AM - 09:20 AM
Case-Based Panel Discussion, PNH – Nicole Birrer, MD
Session Chair: Roland B. Walter, MD, PhD
09:20 AM - 09:35 AM
AML / MDS – Roland B. Walter, MD, PhD
09:35 AM - 09:50 AM
ALL – Ryan Cassaday, MD
09:50 AM - 10:20 AM
Case-Based Panel Discussion – Rachel Davis
Session Chair: Travis Williams, DO
11:05 AM - 11:20 AM
B-Cell Lymphoma – Travis Williams, DO
11:20 AM - 11:35 AM
CLL – Stephen Spurgeon, MD
11:35 AM - 11:50 AM
Outpatient Bispecific Management – Robert Mancini, PharmD
11:50 AM - 12:05 PM
Case-Based Panel Discussion, Practical Issues with Bispecifics – Rachel Davis
Session Chair: Leila Khaddour, MD
12:05 PM - 12:20 PM
Frontline Therapy of Multiple Myeloma – Rebecca Silbermann, MD
12:20 PM - 12:35 PM
Relapsed/Recurrent Sequencing Multiple Myeloma – Ghulam Rehman Mohyuddin, MD
12:35 PM - 12:50 PM
Case-Based Panel Discussion
Session Chair: Clinton Roy Morgan
01:50 PM - 02:05 PM
MPN – Bart L Scott, MD
02:05 PM - 02:20 PM
Use of Cell Therapy in Non-Malignant Conditions – Daniel Couriel, MD, MBA
02:20 PM - 02:35 PM
Case-Based Panel Discussion – Leila Khaddour, MD
02:35 PM - 02:50 PM
What's Next After CDK4/6? ER+/HER2- Metastatic Breast Cancer – Christos Vaklavas, MD
02:50 PM - 03:05 PM
Are we Finally Winning in Triple-Negative Breast Cancer? – Namita Chittoria, MD
03:05 PM - 03:20 PM
Less May be More: De-escalation in HER2+ Disease – Mei Wei, MD
03:20 PM - 03:35 PM
Beyond Survival: Fertility, Survivorship, & Managing Toxicities – Roma Bhatia, MD
03:35 PM - 03:50 PM
New Kids on the Block: Antibody Drug Conjugates – Christos Vaklavas, MD
Venue and map
Accreditations and continuing education
Acknowledgement of Commerical Support
This activity is supported with Independent Medical Education grants from:
- Gilead
- Stemline Therapeutics, Inc
